4.1 Article

Screening and Preventive Strategies in Esophagogastric Cancer

Journal

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA
Volume 26, Issue 2, Pages 163-+

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.soc.2016.10.004

Keywords

Screening; Prevention; Gastric adenocarcinoma; Barrett esophagus; Esophageal adenocarcinoma; Esophageal squamous cell carcinoma

Funding

  1. Nine Point Medical
  2. C2 Therapeutic
  3. CSA Medical
  4. Boston Scientific
  5. Fujinon
  6. National Cancer Institute [U01 CA182940, U54 CA163004]

Ask authors/readers for more resources

Gastric adenocarcinoma, esophageal adenocarcinoma, and esophageal squamous cell carcinoma are among the most prevalent and deadly of malignancies worldwide. Screening and prevention programs will be critical to finally improving outcomes in these diseases. For gastric adenocarcinoma, screening in high-risk populations has significantly reduced mortality. More research is needed on screening high-risk individuals in low-risk populations. For esophageal adenocarcinoma, work is needed to develop efficient and effective techniques in mass screening programs. For most Western populations, current screening is not cost effective. Avoiding environmental risk factors is critical to reducing the incidence of this deadly illness.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available